About Mapi Group
Mapi Group is a Healthcare company based in Lyon (France) founded in 1990, and was acquired by Icon in July 2017. It operates as a real world evidence and post-approval research services are provided. Mapi Group has raised $8.43 million across 1 funding round from investors including ICON and Bryan, Garnier & Co. Its focus areas include Biopharma Outsourcing, Consulting and Regulatory Affairs. Its competitors include ProPharma Group, Validant, PharmaLex, Technical Safety Services and Celegence and 4 more; 2 of its 9 listed competitors have raised funding.
Company details
Mapi Group is a provider of patient centric research services such as real world evidence, market access and health economics and outcomes research, real world strategy, and analytics, language services and strategic regulatory services (including pharmacovigilance) and global late phase research services. The company claims to have expertise in the design and conduct of post approval and commercialization programs for pharmaceuticals, biologics and medical devices. Mapis research trust has more than 4000 COAs (Clinical Outcomes Assessments), 40,000 COA translations, and a research library with more than 29,000 COAs. The company claims to have expertise in rare diseases and gastrointestinal research. The company was acquired by ICON in 2017.
- Headquarters Lyon, France
- SectorsHealthcare
- Website mapigroup.com
- Social LinkedIn X Facebook
- Acquired by Icon (Jul 2017)
Funding Insights of Mapi Group
Mapi Group has successfully raised a total of $8.43M through 1 strategic funding round. The most recent funding activity was a Private Equity Round of $8.43 million completed in June 2005. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $8.43M
- Total Rounds 1
- Last Round Private Equity Round — $8.43M
- First Round $8.43M
(Jun 2005)
- Investors Count 1
All 1 funding rounds of Mapi Group with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2005 | $8.43M | Private Equity Round | – | – |
2 investors in total: 2 institutional.
Investors in Mapi Group
Mapi Group has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include ICON and Bryan, Garnier & Co.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Full service boutique investment bank | 1996 | bryangarnier.com | Paris, France | |
ICON plc is engaged in clinical research and drug development services. | 1990 | iconplc.com | Dublin, Ireland |
Investor details for Mapi Group
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Mapi Group
3 dated milestones of Mapi Group across 27 years, from founding to its latest funding, stage changes and deals.
- Founded Mapi Group is founded.
- Funding First funding round of $8.4M.
- Exit Acquired by Icon.
Competitors of Mapi Group
Mapi Group has 9 listed competitors in our database, 2 of them funded. They include ProPharma Group, Validant, PharmaLex, Technical Safety Services and Celegence, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| propharmagroup.com | 2001 | Saint Paul, United States | – | 999 | Provider of regulatory compliance solutions to pharmaceutical, biotechnology and medical device | |
| validant.com | 2005 | San Francisco, United States | $2.28M | – | Regulatory, compliance, and quality consulting for GxP lifecycles is provided. | |
| pharmalex.com | 1998 | Mannheim, Germany | – | 310 | CRO specializing in regulatory affairs and pharmacovigilance | |
| techsafety.com | 1970 | Berkeley, United States | – | 71 | Healthcare instrumentation, medical gas systems, and related devices are manufactured. | |
| celegence.com | 2017 | Downers Grove, United States | – | – | Regulatory consulting and solutions for pharmaceuticals and medical devices compliance. | |
| clinoutsolutions.com | 2013 | Tucson, United States | – | 38 | Regulatory support and consulting services are provided for clinical outcomes. | |
| trasis.com | 2004 | Ans, Belgium | – | 218 | Provides radiopharmaceutical equipment, synthesis solutions, and custom services for labs. | |
| flyingbrands.co.uk | 1981 | Chelmsford, United Kingdom | – | – | Regulatory services are provided to the biopharma sector. | |
| pharmabioserv.com | 1993 | Dorado, Puerto Rico | $11.75M | – | Provider of regulatory compliance and validation support to life science industries |
Detailed competitors of Mapi Group
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Mapi Group
Websites that share an audience with Mapi Group (mapigroup.com).
Websites whose visitors overlap most with Mapi Group. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| mapi-trust.org | 58% | 138.6K | #303,980 | View details |
Top companies in Biopharma Outsourcing & Drug Delivery
10 companies that operate in the same segment as Mapi Group (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Mapi Group
Mapi Group was founded in 1990 and raised its 1st funding round 15 years after it was founded.
Mapi Group is headquartered in Lyon, France. It is registered at Lyon, Auvergne-rhone-alpes, France.
Mapi Group is a funded company, having raised a total of $8.43M across 1 funding round to date. The company's 1st funding round was a Private Equity Round of $8.43M, raised on Jun 2005.
Mapi Group is a provider of patient centric research services such as real world evidence, market access and health economics and outcomes research, real world strategy, and analytics, language services and strategic regulatory services (including pharmacovigilance) and global late phase research services. The company claims to have expertise in the design and conduct of post approval and commercialization programs for pharmaceuticals, biologics and medical devices. Mapis research trust has more than 4000 COAs (Clinical Outcomes Assessments), 40,000 COA translations, and a research library with more than 29,000 COAs. The company claims to have expertise in rare diseases and gastrointestinal research. The company was acquired by ICON in 2017.
Mapi Group's top competitors include ProPharma Group, PharmaLex and Pharma-Bio Serv.
Mapi Group has 2 investors. Key investors include ICON, and Bryan, Garnier & Co.
Yes. Mapi Group was acquired by Icon in July 2017.